Deepinder Goyal’s Temple Wearable Could Change How You Track Your Body — Here’s What We Know

Forget wristbands and rings — the next big health wearable might sit right on your forehead. Temple, the health-tech venture from Deepinder Goyal, is expected to launch commercially within the next six to twelve months, putting a possible release window in 2027.

What Is Temple?

Unlike smartwatches that track heart rate at the wrist, Temple is worn near the temple and continuously monitors microvascular blood flow to the brain. Goyal believes this gives a far more direct read on the body’s real condition — covering stress, recovery, sleep quality, exercise response, and even meditation effectiveness — rather than relying on proxy metrics like heart rate.

The Big Idea: “Entropy”

At the center of Temple’s pitch is a new biomarker the team calls entropy, said to reflect the real-time physiological cost of simply being alive. The company claims it responds dynamically to stress, sleep, and physical exertion. Goyal has said Temple will launch alongside peer-reviewed research to back these claims — but for now, independent scientific validation is still pending.

Deepinder Goyal’s Temple

Why Doctors Are Skeptical

Indian medical experts, including radiologists, have raised concerns over the lack of clinical validation and regulatory approval. Some have openly questioned whether meaningful deep-brain signals can even be captured through a skin-mounted sensor. Until peer-reviewed data is published, most doctors are urging users to treat the metrics with caution rather than clinical certainty.

A High-Stakes Bet

Temple is reportedly seeking a funding valuation of nearly $500 million, following an earlier $54 million raise — signaling serious investor interest despite the unanswered scientific questions.

For more updates on health-tech launches and emerging wearables, check out TechnoSports for regular coverage.

FAQs